NCT02637687 2025-06-22
SCOUT
Bayer
Phase 1/2 Active not recruiting
Clinical Trials
5 trialsNCT02492711 2025-03-17
SOPHIA
MacroGenics
Phase 3 Completed
NCT02564900 2024-01-22
Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors
Daiichi Sankyo
Phase 1 Completed
NCT02501096 2023-07-20
A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors
Eisai Inc.
Phase 1/2 Completed
NCT02367781 2021-08-09
IMpower130
Hoffmann-La Roche
Phase 3 Completed